These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29680781)

  • 1. Adherence to somatotropin treatment administered with an electronic device.
    Arrabal Vela MA; García Gijón CP; Pascual Martin M; Benet Giménez I; Áreas Del Águila V; Muñoz-Rodríguez JR; Palomo Atance E
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(6):314-318. PubMed ID: 29680781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observational study (ECOS).
    Charmandari E; Vlachopapadopoulou E; Kyritsi EM; Sakellariou D; Koledova E; Nespithal K; Michalacos S
    Growth Horm IGF Res; 2020; 53-54():101336. PubMed ID: 32739654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre.
    Maggio MC; Vergara B; Porcelli P; Corsello G
    Ital J Pediatr; 2018 Sep; 44(1):113. PubMed ID: 30261918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.
    Loche S; Salerno M; Garofalo P; Cardinale GM; Licenziati MR; Citro G; Caruso Nicoletti M; Cappa M; Longobardi S; Maghnie M; Perrone R
    J Endocrinol Invest; 2016 Dec; 39(12):1419-1424. PubMed ID: 27406716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving adherence to GH therapy with an electronic device: first experience with easypod.
    Kirk J
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():549-52. PubMed ID: 19550392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to growth hormone therapy in children and its potential barriers.
    Mohseni S; Heydari Z; Qorbani M; Radfar M
    J Pediatr Endocrinol Metab; 2018 Jan; 31(1):13-20. PubMed ID: 29216008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved adherence and growth outcomes with jet-delivered growth hormone.
    Michaelidou M; Whitten S; Bajaj P; Knight A; Spoudeas HA
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):207-213. PubMed ID: 30844762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences for Injection Device Settings and the Association with Adherence to Growth Hormone Treatment in Patient with Growth Disorders.
    van Dommelen P; Rivera-Romero O; Arnaud L; Zucchiatti C; Koledova E
    Stud Health Technol Inform; 2024 Aug; 316():38-42. PubMed ID: 39176668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone treatment adherence in prepubertal and pubertal children with different growth disorders.
    Hartmann K; Ittner J; Müller-Rossberg E; Schönau E; Stephan R; Ullrich KP; Hoppe B; Ramseger R; Brämswig J
    Horm Res Paediatr; 2013; 80(1):1-5. PubMed ID: 23860437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS).
    Centonze C; Guzzetti C; Orlando G; Loche S;
    J Endocrinol Invest; 2019 Oct; 42(10):1241-1244. PubMed ID: 30968283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in adherence to rhGH treatment: Socioeconomic causes and effect on children's growth.
    De Pedro S; Murillo M; Salinas I; Granada ML; Martinez M; Puig-Domingo M; Andreu A; Bel J
    Growth Horm IGF Res; 2016 Feb; 26():32-5. PubMed ID: 26774403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of nurse-led virtual reviews with growth hormone device-linked patient adherence information: a mixed methods feasibility study.
    Stokes H; Jones J; Worth C; Nicholson J; Fullwood C; Banerjee I
    Front Endocrinol (Lausanne); 2023; 14():1167854. PubMed ID: 37324260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of replacement treatment in isolated growth hormone deficiency].
    Ariza Jiménez AB; Martínez-Aedo Ollero MJ; López-Siguero JP
    An Pediatr (Engl Ed); 2019 May; 90(5):285-292. PubMed ID: 29960877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of treatment adherence with easypod™ in six Italian centers: a real-world experience.
    Cardinale GM; Pesce S; Ingletto D; Mariano M; Catucci A; Corciulo N; Fidotti E
    Minerva Endocrinol; 2019 Sep; 44(3):246-251. PubMed ID: 30482007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring Adherence Rate to Growth Hormone Therapy and Growth Outcomes in Taiwanese Children Using Easypod Connect: Observational Study.
    Su PH; Yang C; Chao MC; Chiang CL
    JMIR Pediatr Parent; 2021 Jan; 4(1):e14774. PubMed ID: 33448936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of adherence to growth hormone treatment on 0-2 year catch-up growth in children with growth hormone deficiency.
    van Dommelen P; Koledova E; Wit JM
    PLoS One; 2018; 13(10):e0206009. PubMed ID: 30356273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital technologies to improve the precision of paediatric growth disorder diagnosis and management.
    Dunkel L; Fernandez-Luque L; Loche S; Savage MO
    Growth Horm IGF Res; 2021 Aug; 59():101408. PubMed ID: 34102547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of Growth Hormone Devices: Matching Devices with Patients.
    Raimer-Hall D; Shea HC
    Pediatr Nurs; 2015; 41(2):72-7. PubMed ID: 26292454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of growth hormone treatment on anthropometrics, metabolic risk, and body composition variables in small for gestational age patients].
    Aurensanz Clemente E; Samper Villagrasa P; Ayerza Casas A; Ruiz Frontera P; Bueno Lozano O; Moreno Aznar LA; Bueno Lozano G
    An Pediatr (Barc); 2017 May; 86(5):240-248. PubMed ID: 27267657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.